For Family and Friends

Your Caregiver Role

A caregiver has many important roles, such as:

  • Getting involved with the healthcare team
  • Giving emotional support

Below, you will find some helpful tips for caregivers.

Helping with the healthcare team

One of your main roles may be to help work with the healthcare team. You can help by:

Care Team
  • Going to doctor appointments with your loved one. Take notes and collect any educational materials that are available
  • Gathering information for your loved one about NHL and treatment options
  • Organizing all of the information that you collect into a binder
  • Creating a list of questions for the healthcare team. For example, ask about treatment options, side effects, procedures, and test results
  • Asking about talking with NHL patients who are willing to share their experiences
  • Helping with insurance information

Supporting your loved one

After receiving a diagnosis of cancer, it is important to understand what your loved one is going through. Common emotions include:

Supporting your loved one
  • Anxiety
  • Fear
  • Hopelessness
  • Depression
  • Anger

Your loved one may have some or all of these feelings. And each person will handle them differently.

So what can you do? You can help just by being there. Many patients ask a friend or loved one to go along on doctor visits. It can be useful to have someone else there to help listen and ask questions. Caregivers can help by keeping track of questions, taking notes, providing insurance information, and helping follow the doctor's instructions at home.

On the next page, we'll talk about how you can help support your loved one emotionally.

 
 

Need help paying for RITUXAN therapy?

Find out about Rituxan Access Solutions®.

Next Section Emotional Support

Indications

RITUXAN® (Rituximab) is indicated for the treatment of patients with:

  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with first-line chemotherapy and, in patients achieving a complete or partial response to RITUXAN in combination with chemotherapy, as single-agent maintenance therapy
  • Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy
  • Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens
  • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent

People with serious infections should not receive RITUXAN.

Important Safety Information

  • RITUXAN can cause serious side effects that can lead to death, including infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
  • RITUXAN has also been associated with serious and life-threatening side effects, including the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
  • The most common side effects of RITUXAN seen in patients with non-Hodgkin's lymphoma were infusion reactions, fever, chills, low white blood cells, infections, body aches, and tiredness. Before starting treatment with RITUXAN it is important to talk to your doctor about your medical history.
  • Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including Medication Guide.

CVP=cyclophosphamide, vincristine, and prednisone or prednisolone; CHOP=cyclophosphamide, doxorubicin, vincristine, and prednisone.